nach oben

European Journal of Pediatrics

Erschienen in:

01.02.2012 | Original Paper

Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review

verfasst von: İstemi Han Celik, Serife Suna Oguz, Gamze Demirel, Omer Erdeve, Ugur Dilmen

Erschienen in: European Journal of Pediatrics | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Multidrug-resistant (MDR) gram-negative bacteria-related nosocomial infections and ventilator-associated pneumonia (VAP) presents an emerging challenge to clinicians. Older antimicrobial agents such as colistin have become life-saving drugs because of the susceptibility of these pathogens. We report our experience with aerosolized colistin in two preterm and one term neonate with Acinetobacter baumannii and Pseudomonas aeruginosa-related VAP who were unresponsiveness to previous antimicrobial treatment. All pathogens were isolated from tracheal aspirate. We used 5 mg/kg (base activity) aerosolized colistin methanesulfonate sodium in every 12 h as an adjunctive therapy for VAP. VAP was treated by 14, 14, and 16-day courses of aerosolized colistin in these patients, respectively. No adverse effect such as nephrotoxicity or neurotoxicity was observed. We found that aerosolized colistin was tolerable and safe, and it may be an adjunctive treatment option for MDR gram-negative bacterial VAP in neonates. Further studies are needed to determine appropriate doses for aerosolized colistin and its eligibility as an alternative treatment choice in newborns.

Baines RD Jr, Rifkind D (1964) Intravenous administration of sodium colistimethate. JAMA 190:278–281PubMedCrossRef

Beringer P (2001) The clinical use of colistin in patients with cystic fibrosis. Curr Opin Pulm Med 7:434–440PubMedCrossRef

Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1–12PubMedCrossRef

Cordero L, Sananes M, Dedhiya P, Ayers LW (2001) Purulence and gram-negative bacilli in tracheal aspirates of mechanically ventilated very low birth weight infants. J Perinatol 21:376–381PubMedCrossRef

Cordero L, Ayers LW, Miller RR, Seguin JH, Coley BD (2002) Surveillance of ventilator-associated pneumoniae in very-low-birth-weight infants. Am J Infect Control 30:32–39PubMedCrossRef

Cunningham S, Prasad A, Collyer L, Carr S, Lynn IB, Wallis C (2001) Bronchoconstriction following nebulised colistin in cystic fibrosis. Arch Dis Child 84:432–433PubMedCrossRef

Falagas ME, Kasiakou SK (2005) Colistin: the reviwal of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 40:1333–1341PubMedCrossRef

Falagas ME, Kasiakou SK (2006) Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 10:R27PubMedCrossRef

Falagas ME, Kasiakou SK, Tsiodras S, Michalopoulos A (2006) The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature. Clin Med Res 4:138–146PubMedCrossRef

10.

Falagas ME, Sideri G, Vouloumanou EK, Papadatos JH, Kafetzis DA (2009) Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis. Pediatr Infect Dis J 28:123–127PubMedCrossRef

11.

Falagas ME, Siempos II, Rafailidis PI, Korbila IP, Ioannidou E, Michalopoulos A (2009) Inhaled colistin as monotherapy for multidrug-resistant gram (−) nosocomial pneumoniae: a case series. Respir Med 103:707–713PubMedCrossRef

12.

Falagas ME, Vouloumanou EK, Rafailidis PI (2009) Systemic colistin use in children without cystic fibrosis: a systematic review of the literature. Int J Antimicrob Agents 33:503 e1–503 e13CrossRef

13.

Falagas ME, Sideri G, Korbila IP, Vouloumanou EK, Papadatos JH, Kafetzis DA (2010) Inhaled colistin for the treatment of tracheobronchitis and pneumoniae in critically ill children without cystic fibrosis. Pediatr Pulmonol 45:1135–1140PubMedCrossRef

14.

Fekety FR Jr, Norman PS, Cluff LE (1962) The treatment of gram-negative bacillary infections with colistin. The toxicity and efficacy of large doses in forty-eight patients. Ann Intern Med 57:214–229PubMed

15.

Garland JS (2010) Strategies to prevent ventilator-associated pneumoniae in neonates. Clin Perinatol 37:629–643PubMedCrossRef

16.

Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140PubMedCrossRef

17.

Gold GN, Richardson AP Jr (1966) An unusual case of neuromuscular blockade seen with therapeutic blood levels of colistin methanesulfonate (Coly-Mycin). Am J Med 41:316–321PubMedCrossRef

18.

Gouyon JB, Guignard JP (2000) Management of acute renal failure in newborns. Pediatr Nephrol 14:1037–1044PubMedCrossRef

19.

Goverman J, Weber JM, Keaney TJ, Sheridan RL (2007) Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population. J Burn Care Res 28:421–426PubMedCrossRef

20.

Hamer DH (2000) Treatment of nosocomial pneumoniae and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med 162:328–330PubMed

21.

Hodson ME, Gallagher CG, Govan JR (2002) A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis. Eur Respir J 20:658–664PubMedCrossRef

22.

Imberti R, Cusato M, Villani P, Carnevale L, Iotti GA, Langer M, Regazzi M (2010) Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration. Chest 138:1333–1339PubMedCrossRef

23.

Iosifidis E, Antachopoulos C, Ioannidou M, Mitroudi M, Sdougka M, Drossou-Agakidou V, Tsivitanidou M, Roilides E (2010) Colistin administration to pediatric and neonatal patients. Eur J Pediatr 169:867–874PubMedCrossRef

24.

Isturiz R (2008) Global resistance trends and the potential impact on empirical therapy. Int J Antimicrob Agents 32(Suppl 4):S201–S206PubMedCrossRef

25.

Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME (2005) Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother 49:3136–3146PubMedCrossRef

26.

Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE (1970) Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med 72:857–868PubMed

27.

Koyama YKA, Tsuchiya A, Takayata A (1950) A new antibiotic “colistin” produced by spore-forming soid bacteria. J Antibiot (Tokyo) 3:457–458

28.

Kwa AL, Loh C, Low JG, Kurup A, Tam VH (2005) Nebulized colistin in the treatment of pneumoniae due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 41:754–757PubMedCrossRef

29.

Levin AS, Barone AA, Penco J, Santos MV, Marinho IS, Arruda EA, Manrique EI, Costa SF (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28:1008–1011PubMedCrossRef

30.

Lin CC, Liu TC, Kuo CF, Liu CP, Lee CM (2010) Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan. J Microbiol Immunol Infect 43:323–331PubMedCrossRef

31.

Lindesmith LA, Baines RD Jr, Bigelow DB, Petty TL (1968) Reversible respiratory paralysis associated with polymyxin therapy. Ann Intern Med 68:318–327PubMed

32.

Lu Q, Girardi C, Zhang M, Bouhemad B, Louchahi K, Petitjean O, Wallet F, Becquemin MH, Le Naour G, Marquette CH, Rouby JJ (2010) Nebulized and intravenous colistin in experimental pneumoniae caused by Pseudomonas aeruginosa. Intensive Care Med 36:1147–1155PubMedCrossRef

33.

Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, Gregorakos L (2003) Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 7:R78–R83PubMedCrossRef

34.

Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME (2005) Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 11:115–121PubMedCrossRef

35.

Nakwan N, Wannaro J, Thongmak T, Pornladnum P, Saksawad R, Chokephaibulkit K (2011) Safety in treatment of ventilator-associated pneumoniae due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report. Pediatr Pulmonol 46:60–66PubMedCrossRef

36.

Perkins RL (1964) Apnea with intramuscular colistin therapy. JAMA 190:421–424PubMedCrossRef

37.

Ratjen F, Rietschel E, Kasel D, Schwiertz R, Starke K, Beier H, van Koningsbruggen S, Grasemann H (2006) Pharmacokinetics of inhaled colistin in patients with cystic fibrosis. J Antimicrob Chemother 57:306–311PubMedCrossRef

38.

Schina M, Spyridi E, Daoudakis M, Mertzanos E, Korfias S (2006) Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin. Int J Infect Dis 10:178–179PubMedCrossRef

39.

Services DoHaH (March, 2009) Ventilator-associated pneumoniae (VAP) event

40.

Souli M, Galani I, Giamarellou H (2008) Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 13(47)

41.

Tallgren LG, Liewendahl K, Kuhlbaeck B (1965) The therapeutic success and nephrotoxicity of colistin in acute and chronic nephropathies with ımpaired renal function. Acta Med Scand 177:717–728PubMedCrossRef

42.

Urban C, Segal-Maurer S, Rahal JJ (2003) Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis 36:1268–1274PubMedCrossRef

43.

Yuan TM, Chen LH, Yu HM (2007) Risk factors and outcomes for ventilator-associated pneumoniae in neonatal intensive care unit patients. J Perinat Med 35:334–338PubMedCrossRef

44.

Zavascki AP, Goldani LZ, Li J, Nation RL (2007) Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother 60:1206–1215PubMedCrossRef

45.

Ziv G, Nouws JF, van Ginneken CA (1982) The pharmacokinetics and tissue levels of polymyxin B, colistin and gentamicin in calves. J Vet Pharmacol Ther 5:45–58PubMedCrossRef

Titel: Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review
verfasst von: İstemi Han Celik
Serife Suna Oguz
Gamze Demirel
Omer Erdeve
Ugur Dilmen
Publikationsdatum: 01.02.2012
Verlag: Springer-Verlag
Erschienen in: European Journal of Pediatrics / Ausgabe 2/2012
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-011-1537-z

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review

Abstract

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Pädiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2012

The effects of detraining on blood adipokines and antioxidant enzyme in Korean overweight children

Normal saline is a safe initial rehydration fluid in children with diarrhea-related hypernatremia

Acute rheumatic fever in the Central Anatolia Region of Turkey: a 30-year experience in a single center

Pediatric tick-borne infections of the central nervous system in an endemic region of Sweden: a prospective evaluation of clinical manifestations

Outcome of ventilated infants born at term without major congenital abnormalities

Feasibility study and control values of transient elastography in healthy children

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Pädiatrie